Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Austrian vaccine panel recommends AstraZeneca jab only for under-65s -APA

Sun, 31st Jan 2021 22:03

VIENNA, Jan 31 (Reuters) - A panel of experts that advises
Austria's government on vaccines recommended on Sunday that
AstraZeneca's coronavirus jab only be given to people
aged 18 to 64 for the time being, national news agency APA
reported.

The decision, which follows a similar move in neighbouring
Germany, is a blow to the country's vaccination plan, which
focuses initially on risk groups such as the elderly. Austria is
acquiring vaccines through the European Union's purchase
agreements and relies heavily on AstraZeneca's drug.

"Due to the smaller (study sample) group size and the small
number of illnesses that occurred, no certain statement on
effectiveness for this age group (65 and over) is possible at
this time," APA quoted a paper by Austria's National Vaccination
Body as saying after the committee met on Sunday.

When more data was available, such as from studies currently
underway in the United States and Britain, a recommendation for
that age group could be possible, it added.

The government is due to review its vaccination plan in
light of the recommendation later in the week.
(Reporting by Francois Murphy; Editing by Daniel Wallis)

Related Shares

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.